Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

Abstract The combination of noradrenergic (reboxetine) plus antimuscarinic (oxybutynin) drugs (reb-oxy) reduced obstructive sleep apnea (OSA) severity but no data are available on its effects on cardiac autonomic modulation. We sought to evaluate the impact of 1-week reb-oxy treatment on cardiovascu...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Elisa Perger, Paolo Castiglioni, Andrea Faini, Davide Soranna, Antonella Zambon, Debora Rosa, Stefano Vicini, Paolo Meriggi, Laura Pini, Claudia Baratto, Sergio Caravita, Ali Azarbarzin, Gianfranco Parati, Carolina Lombardi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2023-02-01
Reeks:	Scientific Reports
Online toegang:	https://doi.org/10.1038/s41598-023-29436-9
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!